Treg
[용어속성] Term
Site-specific PEGylation of interleukin-2 enhances immunosuppression via the sustained activation of regulatory T cells
Research
[키워드] Activation
activation and expansion
Amino acid
Arthritis
Autoimmune diseases
bind
binding
Cell
cytokine
defined
disease
dose
ENhance
glycol
Host
IL-2
IL-2 receptor
immune
Immunosuppression
injection
mouse model
PEGylation
Regulatory
Regulatory T cell
selective
Subcutaneous
sustained
therapeutic
therapeutic efficacy
therapeutic window
Treatment
Treg
Treg cells
trimeric
viral infection
[DOI] 10.1038/s41551-021-00797-8 [Article Type] Research
[DOI] 10.1038/s41551-021-00797-8 [Article Type] Research
Profound Treg perturbations correlate with COVID-19 severity
420
[키워드] Antiviral
Complication
contribute
Convalescent patients
COVID-19
COVID-19 pathology
detrimental
dysfunction
effectors
excessive inflammation
expression
FOXP3
hallmark
IL-18
IL-6
Immune homeostasis
immunological
increase in
Inflammatory response
MOST
notable
outcomes
overexpression
Patient
Perturbation
perturbations
phenotype
poor prognosis
proinflammatory
proinflammatory mediators
proinflammatory molecule
proportion
proportions
Regulatory T cell
responses
responsible
resulting
severe COVID-19
severe COVID-19 patients
severe disease
Severe patient
severity
Significance
similarity
suppress
T cell response
T regulatory cell
the disease
these cell
transcription factor
transcriptional
transcriptomic
Treg
Tregs
tumor Tregs
with COVID-19
[DOI] 10.1073/pnas.2111315118 PMC 바로가기 [Article Type] 420
[DOI] 10.1073/pnas.2111315118 PMC 바로가기 [Article Type] 420
The Binary Model of Chronic Diseases Applied to COVID-19
COVID-19에 적용된 만성 질환의 이진 모델
Immunology
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
alleviate
binary
candidate
Candidates
carrier
carriers
CD8+
CD8+ T cells
chronic
chronic disease
Chronic diseases
class
classification
clinical implication
clinical implications
Co-infection
Contact
contact with
coronavirus
coronavirus disease
Coronavirus disease 2019
corticosteroids (CS)
CoV
COVID-19
disease
drug
drugs
effective
Efficacy
following
Frequency
immune reaction
induce
Infection
JAK inhibitor
Model
pathogen
Pathogens
predict
Rapamycin
Regulatory T cell
regulatory T cells
respiratory
SARS-CoV-2
SARS-COV-2 infection
severe acute respiratory syndrome Coronavirus
severe coronavirus disease
severe COVID-19 patient
statins
T cells
treating COVID-19
Treatment
treatment of COVID-19
Treg
variant
virus
[DOI] 10.3389/fimmu.2021.716084 PMC 바로가기 [Article Type] Immunology
[DOI] 10.3389/fimmu.2021.716084 PMC 바로가기 [Article Type] Immunology
Characterization of T lymphocytes in severe COVID-19 patients
중증 COVID-19 환자의 T 림프구 특성화
Observational Study
[키워드] adaptive
adaptive immunity.
Analysis
Antibody Response
CD8+
Cell
characterization
circulating
concerning
COVID-19
enrolled
healthy control
Immunity
induce
Inflammation
mechanism
pathogenic
Patient
Regulation
SARS-CoV-2
severe COVID-19
severe COVID-19 patient
severe COVID-19 patients
T cell
T lymphocyte
T lymphocytes
therapy
Treg
[DOI] 10.1002/jmv.27037 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1002/jmv.27037 PMC 바로가기 [Article Type] Observational Study
Asymptomatic COVID-19 Individuals Tend to Establish Relatively Balanced Innate and Adaptive Immune Responses
Article
[키워드] acute phase
age
Asymptomatic
Asymptomatic case
asymptomatic individual
Asymptomatic individuals
asymptomatic infection
avoidance
Balanced
Clinical characteristics
Clinical data
Clinical outcome
Coagulation
comprehensive analysis
COVID-19
COVID-19 pandemic
CRP
decrease
demographic characteristics
effective
feature
fibrinogen
immune
Immune cell
Immune phenotype
immune response
immune responses
immunological characteristics
increase in
individual
individual immune response
Inflammatory responses
Innate
Laboratory
Lymphocyte count
marker
MLR
MNKR
Monocytes
NK cells
NLR
pathogenesis of COVID-19
pathogenic mechanism
patients with SARS-CoV-2
performed
Perspective
potential risk
predict
proportion
Protective
Protein
response
Sample size
sample sizes
SARS-CoV-2
significantly higher
symptomatic individual
symptomatic individuals
Th17
the disease
Treg
virus transmission
[DOI] 10.3390/pathogens10091105 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/pathogens10091105 PMC 바로가기 [Article Type] Article
mTOR-Inhibition and COVID-19 in Kidney Transplant Recipients: Focus on Pulmonary Fibrosis
Pharmacology
[키워드] Allograft
antiviral properties
cardiovascular disease
Comorbidity
COVID-19
diabetes
drugs
evaluated
Everolimus
focus
high risk
Immunosuppression
Interaction
kidney transplant recipient
Kidney transplantation
mitigate
mTOR-inhibitors
Patient
pharmacological
progression
proliferation
pulmonary
pulmonary fibrosis
pulmonary toxicity
recipient
reduce
reduction
risk
SARS-CoV-2
SARS-CoV-2 infected patient
severe COVID-19
severe disease
Sirolimus
T lymphocyte
the cytokine storm
therapeutic potential
therapeutic strategy
Transplant
Treg
with COVID-19
[DOI] 10.3389/fphar.2021.710543 PMC 바로가기 [Article Type] Pharmacology
[DOI] 10.3389/fphar.2021.710543 PMC 바로가기 [Article Type] Pharmacology
A novel hypothesis for COVID-19 pathogenesis: Retinol depletion and retinoid signaling disorder
Article
[키워드] Akt, serine/threonine specific protein kinase B
ATRA, All-trans retinoic acid
Autoimmunity
BALF, bronchoalveolar lavage fluid
c-Myc, cellular Myc proto-oncogene
CDC, Centers for Disease Control and Prevention
cisRA, cis isomers of retinoic acid
COVID-19
COVID-19, Coronavirus disease 2019
CRABP-1, cytoplasmic retinoic acid binding protein 1
CRBP-I, cytoplasmic retinol binding protein 1
CXCL9, C-X-C motif chemokine ligand 9
CYP26, cytochrome P450 family 26
CYP27, cytochrome P450 family 27
CYP450
CYP450, cytochrome P450 superfamily of enzymes
Erk, extracellular-signal-regulated kinase
FOXP3
FoxP3, Forkhead box P3 transcription factor
GluR1, glutamate receptor 1
IFN, interferon
IL, interleukin cytokines
IL2RA, interleukin 2 receptor-alpha subunit
Inflammation
IRF, interferon-regulatory factors
JAK, Janus kinases
Lyn, Lyn protein kinase, a member of Src family tyrosine kinases
MAPK, Mitogen-activated protein kinase
MDA5, Melanoma differentiation-associated protein 5
NCoA, nuclear receptor co-activators
NCoR, nuclear receptor co-repressors
NF-κB
NF-κB, nuclear factor kappa light chain enhancer of activated B cells
PI3K, Phosphatidylinositol-3-kinase
PPAR, Peroxisome proliferator-activated receptor
PRR, Pattern Recognition Receptors
RA, retinoic acid
RALDH, retinaldehyde dehydrogenase enzyme
RAR, retinoic acid receptors
RARE, retinoic acid response elements (regulatory DNA sequences bound by retinoic acid receptors)
RBP, retinol binding protein
RDH, retinol dehydrogenase enzymes
retinoic acid
Retinoid signaling
retinol
RIG-I
RIG-I, retinoic acid-inducible gene-I
RLR, RIG-I-like receptor
RORγt
RORγt, Retinoic acid-related orphan receptor gT transcription factor
RXR, retinoid X receptors
SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2
sST2, soluble suppression of tumorigenicity 2
STAT, Signal transducer and activator of transcription
sTNFRSF1A, soluble TNF receptor superfamily member 1A
STRA6, signaling receptor and transporter of retinol
TGF-β, Transforming growth factor-beta
Th17
Th17, T helper 17 cells
TLR, toll-like receptors
TNF, Tumor Necrosis Factor
TRAF, TNF receptor (TNF-R)-associated factor
Treg
Treg, regulatory T cells
Type-I IFN
Type-I IFN, Type I interferon (IFN-α and IFN-β)
VAD, vitamin A deficiency
VitA, vitamin A
vitamin A
Vitamin D
VitD, vitamin D
WHO, World Health Organization
[DOI] 10.1016/j.cellsig.2021.110121 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.cellsig.2021.110121 PMC 바로가기 [Article Type] Article
Associations of immunological features with COVID-19 severity: a systematic review and meta-analysis
Research Article
[키워드] 95%CI
association
B cell
CD3
CD4
CD8
Cell
chemokine
chemokines
Cochrane Library
conducted
COVID-19
COVID-19 patient
COVID-19 patients
cytokine
Cytokines
deaths
disease severity
effective
feature
GM-CSF
help
IFN-γ
IL-10
IL-2
IL-4
IL-5
IL-6
Immune cell
immune cells
immunological
IP-10
MCP-1
mean difference
measurement
Meta-analysis
mild case
mild cases
NK cell
NK cells
no significant difference
RANTES
Result
Severe case
severity
significantly higher
significantly lower
SMD
Spread
supplementary material
systematic review
T cell
TNF-α
Treg
Web of Science
with COVID-19
[DOI] 10.1186/s12879-021-06457-1 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1186/s12879-021-06457-1 PMC 바로가기 [Article Type] Research Article
Clinical Outcome Prediction in COVID-19 Patients by Lymphocyte Subsets Analysis and Monocytes’ iTNF-α Expression
Article
[키워드] Admission
CD4+
CD8+
CD8+ T lymphocyte
cellular
change
clinical
Clinical sign
collected
conducted
coronavirus disease
COVID-19
cytokine
decrease
detect
deteriorate
eosinophil
eosinophils
evaluated
expression
Frequency
group
healthy subjects
Hospitalization
immune system
Immunopathogenesis
IMPROVE
Infection
inflammatory cell
initial
involved
iTNF-α
lymphocyte
Lymphocyte count
lymphocyte counts
lymphocyte subpopulation
Lymphocytes
lymphopenia
modulation
monocyte
Monocytes
neutrophil
Neutrophils
Novel coronavirus
observation
onset of symptoms
outcome
outcomes
parameters
Pathogenesis
Patient
Peripheral blood
phasic
prediction
Predictive
preliminary finding
progression
reduction in
retrospective
SARS-CoV-2
Seven
simple
subject
T lymphocyte
the disease
TNF-α expression
Treatment
Treg
Tregs
[DOI] 10.3390/biology10080735 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/biology10080735 PMC 바로가기 [Article Type] Article